AMGN

AI Research

TrumpRx drug discounts + new CFO Olivier Leonetti + $2.52 dividend

Amgen joined the government-run TrumpRx platform to offer discounted drugs including Amjevita and Repatha, while appointing Olivier Leonetti as Chief Financial Officer effective March 10, 2026. The board declared a $2.52 per share Q2 2026 dividend payable June 5. The stock has climbed 11.88% year-to-date to approximately $366, outperforming many growth peers as investors favor companies with predictable revenues from blockbuster drugs; however, 18 analysts rate it a Hold, suggesting the near-term upside is limited given current pricing.